Spyre Therapeutics, Inc. (SYRE)
(Delayed Data from NSDQ)
$28.70 USD
+1.48 (5.44%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $28.64 -0.06 (-0.21%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | -0.81 |
EPS Last Quarter | -0.86 |
Last EPS Surprise | 4.44% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -3.68 |
Next Year | -3.45 |
EPS (TTM) | -7.77 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | 0.89M | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.81 | -0.80 | -3.68 | -3.45 |
# of Estimates | 4 | 3 | 4 | 4 |
Most Recent Consensus | -0.45 | -0.47 | -2.82 | -1.96 |
High Estimate | -0.45 | -0.47 | -2.82 | -1.96 |
Low Estimate | -1.05 | -1.10 | -4.18 | -4.40 |
Year ago EPS | -3.43 | -2.28 | -29.98 | -3.68 |
Year over Year Growth Est. | 76.38% | 64.91% | 87.73% | 6.05% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.81 | -0.80 | -3.68 | -3.45 |
7 Days Ago | -0.81 | -0.80 | -3.68 | -3.45 |
30 Days Ago | -0.81 | -0.80 | -3.68 | -3.45 |
60 Days Ago | -0.93 | -0.97 | -3.96 | -3.95 |
90 Days Ago | -0.75 | -0.75 | -3.82 | -3.94 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.81 | -0.80 | -3.68 | -3.45 |
Zacks Consensus Estimate | -0.81 | -0.80 | -3.68 | -3.45 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.86 | -1.20 | -2.28 | -3.43 | NA |
Estimate | -0.90 | -0.90 | -0.48 | -0.44 | NA |
Difference | 0.04 | -0.30 | -1.80 | -2.99 | -1.26 |
Surprise | 4.44% | -33.33% | -375.00% | -679.55% | -270.86% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more